A Prospective Real-World Observational Study of Nanocrystalline Megestrol Acetate in Patients With Cancer Cachexia

Recruiting now · Phase 4

Conditions studied: Clinical Characteristics and Treatment Outcomes of Malignant Tumor Cachexia, Multicenter Observational Study

In brief

This study is a prospective, real-world observational study. The objective is to evaluate the effectiveness and safety of nanocrystalline megestrol acetate in patients with cancer cachexia in real-world settings. Eligible participants were patients diagnosed with cancer cachexia who were scheduled to receive treatment with nanocrystalline megestrol acetate.

Key facts

Study ID
NCT07243379
Run by
Changchun GeneScience Pharmaceutical Co., Ltd.
People needed
495
Starts
2025-09-25
Expected to finish
2027-06-30
Last updated by the study team
2025-11-21

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.